logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > AZD-4547 CAS 1035270-39-3

AZD-4547 CAS 1035270-39-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1035270-39-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
1035270-39-3
Appearance::
Crystalline Solid
Molecular Formula::
C26H33N5O3
Molecular Weight::
463.57200
EINECS NO::
681-057-4
MDL NO::
MFCD22580423
CAS NO::
1035270-39-3
Appearance::
Crystalline Solid
Molecular Formula::
C26H33N5O3
Molecular Weight::
463.57200
EINECS NO::
681-057-4
MDL NO::
MFCD22580423
AZD-4547 CAS 1035270-39-3

Product Description:

Product Name: AZD-4547 CAS NO: 1035270-39-3

 

 

Synonyms:

N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide;

QCR-89;

 

 

Chemical & Physical Properties:

Appearance: Crystalline solid

Assay :≥98.0%

Density: 1.189

Boiling Point: 621.7±55.0℃ (Predicted)

PKa: 13.66±0.10 (Predicted)

Flash Point: 329.8±31.5℃

Vapor Pressure: 0.0±1.8 mmHg at 25℃

Index of Refraction: 1.602

 

 

AZD4547 is a bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor (FGFR) tyrosine kinases. AZD4547 is particularly effective in inhibiting FGFR1, 2, and 3 tyrosine kinases and is under clinical investigation for the treatment of FGFR-dependent tumors. AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2.5 nM/1.8 nM in cell-free assays, weaker activity against FGFR4, VEGFR2(KDR), and little activity observed against IGFR, CDK2, and p38. Phase 2/3.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.